- Home
- ARQT vs OUST Comparison
ARQT vs OUST Comparison
Compare ARQT & OUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | OUST |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.9B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARQT | OUST |
|---|---|---|
| Price | $26.62 | $35.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $34.00 | ★ $39.25 |
| AVG Volume (30 Days) | 1.8M | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | 48.56 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $376,072,000.00 | $169,384,000.00 |
| Revenue This Year | $34.85 | $33.20 |
| Revenue Next Year | $29.39 | $37.27 |
| P/E Ratio | $824.50 | ★ N/A |
| Revenue Growth | ★ 91.34 | 52.46 |
| 52 Week Low | $16.68 | $16.40 |
| 52 Week High | $31.77 | $63.79 |
Technical Indicators
Market Signals| Indicator | ARQT | OUST |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 42.36 |
| Support Level | $24.91 | $33.03 |
| Resistance Level | $25.21 | $38.38 |
| Average True Range (ATR) | 1.03 | 1.67 |
| MACD | 0.22 | -0.11 |
| Stochastic Oscillator | 59.88 | 32.02 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.